Navigation Links
Cholesterol Plays Role in Heart Failure Risk
Date:11/24/2009

Pumping ability reduced in those with undesirable blood levels, analysis shows

TUESDAY, Nov. 24 (HealthDay News) -- Abnormal cholesterol levels can significantly increase the risk of heart failure, a new study has found.

U.S. researchers analyzed data on 6,860 participants in the National Heart, Lung, and Blood Institute's Framingham Heart Study. None of the participants, average age 44, had coronary heart disease at the start of the study. After about 26 years of follow-up, 680 people had developed heart failure.

The incidence of heart failure was:

  • 12.8 percent in participants with low levels of high-density lipoprotein (HDL, or "good") cholesterol. Low HDL is less than 40 milligrams per deciliter (mg/dL) in men and less than 50 mg/dL in women.
  • 6.1 percent among participants with desirable HDL levels (at least 55 mg/dL in men and 65 mg/dL in women).
  • 13.8 percent in participants with high levels (at least 190 mg/dL) of non-HDL cholesterol, which includes triglycerides and low-density lipoprotein (LDL, or "bad") cholesterol.
  • 7.9 percent in those with desirable levels (less than 160 mg/dL) of non-HDL cholesterol.

When the researchers factored in age, sex, body mass index, blood pressure, diabetes and smoking, the risk of heart failure was 29 percent higher in participants with high non-HDL cholesterol than in those with lower levels, and 40 percent lower in those with high HDL-cholesterol than in those with lower levels.

Further analysis showed that the risk of heart attack was 13 percent higher in participants with high non-HDL cholesterol and 25 percent lower in those with high HDL cholesterol.

"This study goes a step further in implicating cholesterol levels (both HDL and non-HDL) in heart failure and suggests that cholesterol-altering therapy may have long-term benefits in preventing heart failure above and beyond its effects on preventing [hear
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Incidence of High Cholesterol Drops in U.S.
2. Study Raises New Questions About Cholesterol Drug Zetia
3. American Heart Association Late Breaking Clinical Trial Report: In Patients on Statins, Raising Good Cholesterol with Niacin, but not Reducing Bad Cholesterol with Ezetimibe, Decreases Plaque Build-Up
4. New Study Raises New Questions About Cholesterol Drug Zetia
5. Cholesterol Measurements May Be Made Easier
6. Cholesterol and Cancer: Answers and Some New Questions
7. Low Cholesterol May Help Prevent Cancer
8. Researchers identify the 3 killer indicators that are even worse than high cholesterol
9. Household Chemicals May Affect Cholesterol Levels
10. Cholesterol Drugs May Help Prevent Flu Deaths
11. Cholesterol-lowering medicines may be effective against cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... from Boston University,s Slone Epidemiology Center have found ... risk for type 2 diabetes in African American ... American Journal of Epidemiology , is the ... neighborhood socioeconomic status and incidence of type 2 ... African-American women. , Type 2 diabetes is estimated ...
(Date:2/9/2010)... February 8, 2010- The research group of Dr. Franois ... de Montral (IRCM), in collaboration with the team of ... of Toronto) accomplished a technical breakthrough: they mapped all ... yeast Saccharomyces cerevisiae . The method used by ... has been published online today in the scientific journal ...
(Date:2/9/2010)... in infants born prematurely in the US, according to ... (LUHS). These findings were reported at the 30th Annual ... They also were published in the latest issue of ... , Researchers reported that CP is associated with inflammation ... inflammation is more common in premature births from preterm ...
(Date:2/9/2010)... , Feb. 9 The Quantum Foundation ... the School District of Palm Beach County that ... fit. The Robert Wood Johnson Foundation (RWJF) recently announced a ... and access to affordable healthy foods for children and families ... communities. Based on a rigorous selection process that drew ...
(Date:2/9/2010)... forms of the protein cyclin E renders the ... (ER+) breast cancers, researchers from The University of ... Clinical Cancer Research . , The M. ... professor in M. D. Anderson,s Department of Experimental ... Stringer Professor in Medical Oncology, found evidence that ...
Breaking Medicine News(10 mins):Health News:Neighborhood socioeconomic status and diabetes 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 3Health News:Incidence of cerebral palsy on rise in US 2Health News:Planting Seeds to Fight Childhood Obesity 2Health News:Low forms of cyclin E reduce breast cancer drug's effectiveness 2Health News:Low forms of cyclin E reduce breast cancer drug's effectiveness 3
... entry-level price point , , SALT ... SNCI ) the only U.S.-based publicly traded manufacturer of digital ... Velocity series. The Velocity 6 now becomes the latest product ... , , Sonic Innovations, CEO Sam ...
... get cosmetic surgery but either couldn,t afford it or were afraid ... out of cosmetic surgery with a nonsurgical facelift that,s extremely safe, ... could you ask for? , ... Coral Gables, FL ...
... announced its nominations for the prestigious "Super Dentist" award given to ... again nominated a top practitioner in the area of Cosmetic Dentistry. ... ... Michael McCarty of Austin Smiles was recently nominated as ...
... Foundation is creating a new inter-disciplinary research network to help ... aging society. In the middle of the next decade, ... of which is that those over age 60 will outnumber ... increasingly gray in subsequent decades, we are not well prepared ...
... could be key to new disease-fighting therapies , , THURSDAY, ... suggests inhibiting a protein that allows certain tumor cells ... treatments. , A study by Pierre Sonveaux and colleagues ... tumor cells use different fuel sources depending on whether ...
... 5, the Johns Hopkins Bloomberg School of Public Health and ... symposium to mark the 60th Anniversary of the Universal Declaration ... The Work Ahead of Us," will evaluate progress in public ... Navanethem Pillay, SJD, LLM, the United Nations High Commissioner for ...
Other Medicine News:Health News:Sonic Innovations Launches New Product to Meet Growing Consumer Need and Demand for Digital Hearing Aids 2Health News:Sonic Innovations Launches New Product to Meet Growing Consumer Need and Demand for Digital Hearing Aids 3Health News:Miami's Soluna MD Introduces New Cosmetic Surgery Facelift Technique With Permalift 2Health News:Miami's Soluna MD Introduces New Cosmetic Surgery Facelift Technique With Permalift 3Health News:Miami's Soluna MD Introduces New Cosmetic Surgery Facelift Technique With Permalift 4Health News:Texas Super Dentist Awards Announced--Dr. Michael McCarty From Austin Smiles Is Awarded For The Third Year In A Row 2Health News:New MacArthur network to examine impact of aging society 2
(Date:2/9/2010)... Mass. , Feb. 9 STD Med, ... Stoughton, Massachusetts is pleased to announce the acquisition ... Bridgewater, Massachusetts . This is in addition to the current ... growing and advancing the company during these difficult financial times," ... this growth to the premise on which STD Med was ...
(Date:2/9/2010)... , Feb. 9 Volcano ... and manufacturer of precision intravascular therapy guidance tools ... coronary and peripheral vascular disease, announced today that ... device line from Lumen Biomedical. Volcano became the ... May 2009 . This acquisition reinforces Volcano,s ...
(Date:2/9/2010)... Calif. , Feb. 9 ... announced financial guidance for the full year 2010. ... $147 to $165 million .  In addition, ... in 2010, with earnings per share for the ... $0.02 , excluding any mark-to-market adjustments relating to ...
Breaking Medicine Technology:STD Med Inc. Acquires Facility for Manufacturing and Start-Ups 2Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 2Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 3Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 4Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 5ISTA Pharmaceuticals Announces 2010 Financial Guidance 2ISTA Pharmaceuticals Announces 2010 Financial Guidance 3ISTA Pharmaceuticals Announces 2010 Financial Guidance 4ISTA Pharmaceuticals Announces 2010 Financial Guidance 5Alcohol consumption may increase breast cancer recurrence risk 63050 1Alcohol consumption may increase breast cancer recurrence risk 63050 2Potential new heart attack biomarker uncovered 11085 1Potential new heart attack biomarker uncovered 11085 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 15138 1Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 15138 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 15138 3
... - King,Pharmaceuticals, Inc. (NYSE:KG) reported today that ... Altace (ramipril) 20mg and the,combination of ALTACE ... weekend at the American Society of Hypertension,Inc. ... 2007) in Chicago, Illinois. The clinical trial ...
... being presented today at Digestive Disease Week -, ... today,announced the presentation of data from a Phase ... improved bowel function,in patients with constipation- predominant irritable ... well tolerated with,a low incidence of adverse events. ...
Other Medicine Technology:King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy,of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For,24-hour Blood Pressure Control 2King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy,of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For,24-hour Blood Pressure Control 3King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy,of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For,24-hour Blood Pressure Control 4King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy,of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For,24-hour Blood Pressure Control 5Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4
... Neonates to adults, the entire series of ... knowledge of the needs of care providers ... in the accuracy. You can see it ... in the performance, year after year. Every ...
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
Medicine Products: